News

News

20 September 2017: Sysmex partner with Pantai Premier Pathology and Merck for new liquid biopsy testing to be used in Metastatic cases of colorectal cancer

Colorectal cancer is the second most commonly occurring cancer in Malaysia (Malaysian National Cancer Registry Report 2007-2011).  A new liquid biopsy testing to monitor the progression of metastatic cases of colorectal cancer is now available at Pantai Premier Pathology, Malaysia. The new liquid biopsy testing allows oncologists and surgeons to examine a ‘snapshot’ of the […]

13 September 2017: Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Second Consecutive Year

The Dow Jones Sustainability Indexes are developed through collaboration between S&P Dow Jones Indices of the United States and Robeco SAM, a Swiss research specialist in the area of socially responsible investment. This year Sysmex has been selected for inclusion in the DJSI World for the second consecutive year.

10 August 2017: Sysmex, Hyogo Pharmaceutical Society and Shinkai Transport Systems Enter Agreement to Cooperate on Disaster Relief Activities

Creating a System for Operating Mobile Pharmacies as a Disaster Response Measure – Sysmex Corporation, the Hyogo Pharmaceutical Society and Shinkai Transport Systems, Ltd. announce the signing of an agreement to cooperate on disaster relief activities, aimed at operating mobile pharmacies in times of disaster.

01 June 2017: Sysmex Continuing to Participate in the Global Health Innovative Technology Fund

In order to continue supporting the initiatives of the GHIT Fund, which aims to assist in the application of Japanese technological innovation to healthcare in developing countries, we will be extending our provision of donations for a five-year period from 2018. By participating in the GHIT Fund, we will move forward with initiatives to develop […]

01 June 2017: Sysmex Opens New R&D Facility with a View toward the Realization of Personalized Medicine

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has opened a new R&D facility within its Kawasaki INnovation Gateway at SKYFRONT in the city of Kawasaki, Kanagawa Prefecture, to pursue R&D in bioinformatics, a key technology toward the realization of personalized medicine.

31 May 2017: Sysmex Acquires UK Company to Expand into New Business Domains toward Personalized Medicine

Sysmex Corporation has reached an agreement with Oxford Gene Technology IP Limited (“OGT”) to acquire all shares in OGT. Through this move, Sysmex aims to obtain OGT’s business and expertise in the cytogenetics1 domain and its reagent development capabilities used in next-generation sequencers (NGSs)2, thereby reinforcing its base in the life science business.

25 May 2017: Sysmex Receives Invention Award in the 2017 National Commendation for Invention

Sysmex Corporation has received the Invention Award in the National Commendation for Invention1, sponsored by the Japan Institute of Invention and Innovation, for its hematology analyzers that enables the rapid evaluation of the effects of administering iron preparations. The award ceremony is scheduled to be held in Tokyo on Monday, June 12.

21 May 2017: Sysmex New Zealand Commence Direct Sales of Urinalysis Instrument Portfolio

Sysmex New Zealand has been synonymous with the Delphic and Eclair suite of lab and clinical IT solutions for over three decades. The Sysmex New Zealand team are excited to announce, effective 1st May we will be managing the direct sales and support of the Sysmex Urinalysis instrument portfolio.

21 May 2017: Sysmex New Zealand Announce New Management Roles

Sysmex New Zealand has appointed a new senior management team. James Webster has stepped aside as Sysmex New Zealand CEO to focus his full attention on his role as Sysmex Australia CEO. Assuming the position of Sysmex New Zealand CEO is Arjit Bhana, formerly the company’s General Manager.

11 April 2017: Sysmex Receives the Fiscal 2017 Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology

Sysmex Corporation has received the Fiscal 2017 Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology, Prize for Science and Technology (Development Category), for its Development of White Blood Cell Five-Part Differentiation and an Atypical White Blood Cell Differentiation Method.

03 April 2017: Sysmex Establishes New Company, Sysmex Harmony, to Promote the Employment of People with Disabilities

Sysmex Corporation announces the establishment of a new company, Sysmex Harmony Co., Ltd., to promote the employment of people with disabilities.

09 February 2017: Sysmex Enters into Research Collaboration Agreement in Relation to Cancer and Rare Diseases with the University of Tokyo

Sysmex Corporation and the University of Tokyo have entered into a research collaboration agreement involving the development of a target gene panel. The objective is to analyze lung cancer, sarcoma and other specified types of diseases, and analyze genetic mutations related to rare diseases with a view to the clinical application of genomic medicine.

Please help us to serve you better by sharing your experience.

Do you find the resources provided at this site useful?

What scientific topics you would be most interested to read?

close